Tri-Coast Pharmacy Recalls BCAA Vials Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 265 vials of compounded BCAA solution because the agency cannot ensure the products are sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Per the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated Severe (4). While no specific injuries are listed, the lack of sterility assurance in a compounded drug is a significant hazard warranting a high severity rating under the Class II criteria.
Plain-English summary
Tri-Coast Pharmacy is recalling 265 vials of BCAA (30 ML) compounded solution. The product contains Isoleucine (L) 15 mg, Leucine (L) 10 mg, Valine 40 mg, and Lidocaine HCL 10 mg/mL. The recall is being conducted because there is a lack of assurance of sterility for the affected products.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. Specific lot codes and expiration dates involved in the recall are 07222016A (01/18/2017), 08162016C (02/12/2017), 08042016A (01/31/2017), 11012016I (04/30/2017), and 10172016B (02/28/2017). The products were distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot codes and stop using the product if it matches the recalled description. The FDA has classified this as a Class II recall, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- BCAA (30 ML) (Isoleucine (L) 15 mg + Leucine (L) 10 mg+ Valine 40 mg+ Lidocaine HCL 10 mg/mL). Compounded by Tri-Coast Pharmacy.
- Manufacturer
- Tri-Coast Pharmacy
- Category
- Drug — Compounded Medication
- Affected units
- 265
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 08162016C (02/12/2017)
- 08042016A (01/31/2017)
- 11012016I (04/30/2017)
- 10172016B (02/28/2017).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29